USPTO serial 79432839
METIRRA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 23, 2026
- Examiner
- TENG, SIMON
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with METIRRA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical products for the prevention and treatment of cancer; medical preparations for the treatment of cancer; pharmaceutical and veterinary preparations and substances for the treatment of cancerous tumors; medical biological preparations and substances for the prevention and treatment of infectious diseases; diagnostic biomarker reagents for medical purposes; diagnostic biomarkers for in vitro testing for medical use; diagnostic biomarkers for use in assessment of genomic analysis for medical use; diagnostic biomarkers for use in assessment of chemical skin sensitizers for medical use; diagnostic biomarkers for use in assessment of toxicological property of chemical compounds and mixtures for medical use; biopharmaceuticals for the treatment of cancer; biotechnological preparations for medical purposes and medical use, namely, biological reagents for medical purposes; biocides; diagnostic biomarkers for use in assessment of chemical respiratory sensitizers for medical use; diagnostic reagents and assays for detecting antigens for medical purposes; biotherapeutics, namely, therapeutic pharmaceutical for the treatment of cancer; pharmaceutical biosimilars for human use for the treatment of cancer; medical preparations, namely, immunotherapeutic agents for the treatment and prevention of cancers and tumors; diagnostic biomarkers and medical antibodies for use in medical imaging | ACTIVE | — |
| 044 | Disease diagnosis services being performing diagnosis of diseases; medical analysis for the diagnosis and treatment of persons; medical analysis services for the diagnosis and treatment of persons; medical analysis services for cancer diagnosis and prognosis; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical services; medical services, namely, consulting services in the field of healthcare; medical consultancy services; provision of information in the field of cancer prevention, screening, diagnosis, and treatment; RNA or DNA analysis for cancer diagnosis and prognosis; medical pathology services; medical services in the field of oncology; providing medical information to patients and medical professionals in the form of medical reports in the field of cancer prevention, screening, diagnosis, and treatment; medical information; consulting services in the field of medical care | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Metirra Pty Ltd
- Other trademarks owned by Metirra Pty Ltd
- Other trademarks owned by Metirra Pty Ltd
- Other trademarks owned by Envision Sciences Pty Ltd
- Other trademarks in Class 005
- Other trademarks in Class 044
- Similar marks named METIRRA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 23, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 23, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 5, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 5, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 29, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 6, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 1, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 1, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 1, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 13, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 13, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 13, 2026 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Mar 13, 2026 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Mar 12, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 26, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 26, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 30, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 29, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 29, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 28, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 28, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 22, 2026 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Sep 26, 2025 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Sep 18, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |